SP600125 is a broad-spectrum JNK inhibitor for JNK1, JNK2 and JNK3 with IC50 of 40 nM, 40 nM and 90 nM, respectively; 10-fold greater selectivity against MKK4, 25-fold greater selectivity against MKK3, MKK6, PKB, and PKCα, and 100-fold selectivity against ERK2, p38, Chk1, EGFR etc.
Chemical Name:
2H-Dibenzo[cd,g]indazol-6-one
Biological Activity: |
Biological Activity |
SP600125 is a broad-spectrum JNK inhibitor for JNK1, JNK2 and JNK3 with IC50 of 40 nM, 40 nM and 90 nM, respectively; 10-fold greater selectivity against MKK4, 25-fold greater selectivity against MKK3, MKK6, PKB, and PKCα, and 100-fold selectivity against ERK2, p38, Chk1, EGFR etc. |
Technical Data: |
M.W. |
220.23 |
Formula: |
C<sub>14</sub>H<sub>8</sub>N<sub>2</sub>O |
Solubility: |
DMSO |
Purity: |
98% |
Storage: |
-20℃ |
CAS No: |
129-56-6 |
References: |
References |
Bennett BL, et al. Proc Natl Acad Sci U S A, 2001, 98(24), 13681-13686.
Joiakim A, et al. Drug Metab Dispos, 2003, 31(11), 1279-1282.
Schmidt M, et al. EMBO Rep, 2005, 6(9), 866-872.
Colombo R, et al. Cancer Res, 2010, 70(24), 10255-64.
Vaishnav D, et al. Biochem Biophys Res Commun, 2003, 307(4), 855-860.
Kim JA, et al. Oncogene, 2010, 29(11), 1702-1716. |